; (B) shall not be directly or indirectly based on, or contingent upon— (i) a drug price (such as wholesale acquisition cost) or drug benchmark price (such as average wholesale price); (ii) the amount of discounts, rebates, fees, or other direct or indirect remuneration with respect to prescription drugs prescribed to the participants, beneficiaries, or enrollees in the group health plan or coverage involved; or (iii) any other amounts prohibited by the Secretary, the Secretary of Labor, and the Secretary of the Treasury. (2) Definitions In this section— (A) the term bona fide service fee means fair market value for a bona fide, itemized service actually performed on behalf of an entity, that would otherwise perform (or contract for) in the absence of the service arrangement and that are not passed on in whole or in part to a client or customer, whether or not the entity takes title to the drug; (B) the term pharmacy benefit manager means any person, business, or other entity such as a third-party administrator, regardless of whether it identifies itself as a pharmacy benefit manager, that, either directly or through an intermediary (including an affiliate, subsidiary, or agent) or an arrangement with a third party— (i) acts as a price negotiator for prescription drugs on behalf of a group health plan or health insurance issuer offering group health insurance coverage